47 related articles for article (PubMed ID: 17596492)
1. Acute insulin response and beta-cell compensation in normal subjects treated with olanzapine or risperidone for 2 weeks: response to Hardy et al.
Jindal RD
Diabetes Care; 2007 Jul; 30(7):e69; author reply e70. PubMed ID: 17596492
[No Abstract] [Full Text] [Related]
2. Olanzapine, not resperidone, exacerbates beta-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them.
Park S; Sang Mee Hong ; Il Sung Ahn ; Sung Hoon Kim
J Psychopharmacol; 2010 Jul; 24(7):1105-14. PubMed ID: 19965940
[TBL] [Abstract][Full Text] [Related]
3. Acute insulin response and beta-cell compensation in normal subjects treated with olanzapine or risperidone for 2 weeks.
Hardy TA; Meyers AL; Yu J; Shankar SS; Steinberg HO; Porksen NK
Diabetes Care; 2007 Jan; 30(1):157-8. PubMed ID: 17192353
[No Abstract] [Full Text] [Related]
4. Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs.
Ader M; Kim SP; Catalano KJ; Ionut V; Hucking K; Richey JM; Kabir M; Bergman RN
Diabetes; 2005 Mar; 54(3):862-71. PubMed ID: 15734866
[TBL] [Abstract][Full Text] [Related]
5. The antipsychotic olanzapine induces apoptosis in insulin-secreting pancreatic β cells by blocking PERK-mediated translational attenuation.
Ozasa R; Okada T; Nadanaka S; Nagamine T; Zyryanova A; Harding H; Ron D; Mori K
Cell Struct Funct; 2013; 38(2):183-95. PubMed ID: 23812432
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp.
Sowell M; Mukhopadhyay N; Cavazzoni P; Carlson C; Mudaliar S; Chinnapongse S; Ray A; Davis T; Breier A; Henry RR; Dananberg J
J Clin Endocrinol Metab; 2003 Dec; 88(12):5875-80. PubMed ID: 14671184
[TBL] [Abstract][Full Text] [Related]
7. Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents.
Ugale RR; Hirani K; Morelli M; Chopde CT
Neuropsychopharmacology; 2004 Sep; 29(9):1597-609. PubMed ID: 15100702
[TBL] [Abstract][Full Text] [Related]
8. The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients.
Kinon BJ; Stauffer VL; McGuire HC; Kaiser CJ; Dickson RA; Kennedy JS
J Am Med Dir Assoc; 2003; 4(4):189-94. PubMed ID: 12837139
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels.
Roerig JL; Steffen KJ; Mitchell JE; Crosby RD; Gosnell BA
J Clin Psychopharmacol; 2008 Feb; 28(1):21-6. PubMed ID: 18204336
[TBL] [Abstract][Full Text] [Related]
10. [Effect of atypical antipsychotics on metabolism].
Bakos CD; Berecz R; Degrell I
Neuropsychopharmacol Hung; 2004 Jun; 6(2):86-9. PubMed ID: 15787207
[TBL] [Abstract][Full Text] [Related]
11. Smokers and nonsmokers equally affected by olanzapine-induced weight gain: metabolic implications.
Lasser RA; Mao L; Gharabawi G
Schizophr Res; 2004 Feb; 66(2-3):163-7. PubMed ID: 15061249
[TBL] [Abstract][Full Text] [Related]
12. The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating.
Bubeníková V; Votava M; Horácek J; Pálenícek T; Dockery C
Pharmacol Biochem Behav; 2005 Apr; 80(4):591-6. PubMed ID: 15820528
[TBL] [Abstract][Full Text] [Related]
13. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia.
Lang DJ; Kopala LC; Vandorpe RA; Rui Q; Smith GN; Goghari VM; Lapointe JS; Honer WG
Am J Psychiatry; 2004 Oct; 161(10):1829-36. PubMed ID: 15465980
[TBL] [Abstract][Full Text] [Related]
14. Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications.
Savina I; Beninger RJ
Schizophr Res; 2007 Aug; 94(1-3):128-38. PubMed ID: 17560766
[TBL] [Abstract][Full Text] [Related]
15. A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model.
Boyda HN; Tse L; Procyshyn RM; Wong D; Wu TK; Pang CC; Barr AM
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):945-54. PubMed ID: 20452386
[TBL] [Abstract][Full Text] [Related]
16. [Prolactin secretion disturbances in schizophrenic patients treated with 2nd generation antipsychotics--risperidone and olanzapine].
Wyszogrodzka-Kucharska A; Kunert-Radek J; Rabe-Jabłońska J
Psychiatr Pol; 2005; 39(6):1143-55. PubMed ID: 16526181
[TBL] [Abstract][Full Text] [Related]
17. Initiation of atypical antipsychotic agents and health outcomes in patients with schizophrenia.
Ren XS; Lee AF; Huang YH; Hamed A; Herz L; Miller DR; Kazis LE
J Clin Pharm Ther; 2004 Oct; 29(5):471-81. PubMed ID: 15482392
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells.
Engl J; Laimer M; Niederwanger A; Kranebitter M; Starzinger M; Pedrini MT; Fleischhacker WW; Patsch JR; Ebenbichler CF
Mol Psychiatry; 2005 Dec; 10(12):1089-96. PubMed ID: 16130009
[TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
Oerther S; Ahlenius S
J Pharmacol Exp Ther; 2000 Feb; 292(2):731-6. PubMed ID: 10640312
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia.
Baptista T; Martinez M; Lacruz A; Arellano A; Mendoza S; Beaulieu S; Hernández L; Contreras Q; Galeazzi T; Vargas D
Schizophr Res; 2007 Jan; 89(1-3):350-2. PubMed ID: 17029751
[No Abstract] [Full Text] [Related]
[Next] [New Search]
